News

Chordate enrolls first patient in a study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the preventive treatment of chronic migraine 2018-03-23

Chordate enrolls first patient in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the preventive treatment of chronic migraine. Kista, Sweden, March 23, 2018 — Chordate Medical Holding AB’s (publ) (“Chordate”), a specialty medtech company that focuses on developing and commercializing neuromodulating treatment systems for treating non-allergic rhinitis and migraine, today announced that the first patient was […]

CHORDATE WILL PARTICIPATE IN EUROPEAN RHINOLOGIC SOCIETY MEETING 2018-03-21

Chordate Medical will participate in European Rhinologic Society Meeting (ERS) in London 22-26 April. http://www.erslondon2018.com/

CHORDATE AND STERIPOLAR EXHIBIT DURING ENT-CONGRESS 2018-02-08

Together with Steripolar, Chordate exhibits during the ENT-congress in Helsinki, Finland February 8-9.

CHORDATE SIGNS DISTRIBUTION AGREEMENT FOR FINLAND 2018-02-05

Chordate signs distribution agreement with Steripolar for Finland.

Chordate and Nanos Medical signs a Letter of Intent for a joint venture agreement regarding China 2017-12-18

Press Release Chordate and Nanos Medical signs a Letter of Intent for a joint venture agreement regarding China Kista-Shanghai, 18th December 2017. Chordate Medical Holding AB (publ.) (“Chordate”) has through its subsidiary Chordate Medical AB signed a letter of intent regarding a joint venture with Nanos Medical (Shanghai) Limited (” Nanos Medical “) mainly related to the Chinese market. Nanos Medical will own 67 percent […]

Chordate will attend the Rhinology Future Debate 2017-12-04

Chordate will be attending the Rhinology Future Debate organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) in Brussels 8th of December. EUFOREA brings together key opinion leaders in the field of respiratory diseases, industrial partners and patients in a forum on novel developments in the rhinology and the respiratory field. The Rhinology Future Debates is a clinician-orientated meeting […]

CHORDATE TAKES PART IN EUROPEAN RHINOLOGY RESEARCH FORUM 2017-11-07

Chordate will take part in European Rhinology Research Forum 2017. It will be held in Brussels, Belgium on 9-10 November organized by European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and the European Rhinologic Society (ERS).

NEW CLINICAL PAPER PUBLISHED 2017-07-07

Annals of Noninvasive Electrocardiology recently published a paper on KOS effect on the Autonomic Nervous System (ANS). This was a sub-analysis from a Safety Study performed at the Karolinska Trial Alliance. ECGs were evaluated by iCardiac in the US, and findings were that KOS treatment had an effect on Heart Rate Variability (HRV) as a sign of effect on the ANS. Results from the Safety […]

TO HELP PATIENTS WITH RHINITIS IN SAUDI ARABIA 2017-05-22

To help patients with rhinitis, Chordate’s treatment method is launched in Saudi Arabia. A successful launch meeting was organized in Jeddah, Saudi Arabia. The scientific programme was moderated by Prof. Tariq Jamal, King Abdulaziz University, Jeddah. .

LAUNCH OF CHORDATE´S KOS TREATMENT IN SAUDI ARABIA 2017-05-16

Almothihel Medical and Chordate Medical launch KOS treatment for Non-Allergic Rhinitis in Saudi Arabia. A launch meeting will be held on ‘Where are we heading in the treatment of Non Allergic Rhinitis. A new innovation’ organized by the distributor Almothihel Medical and Chordate Medical. May 16, 2017—Almothihel Medical Est. and Chordate Medical AB, announce the launch of the Kinetic Oscillation Stimulation, KOS treatment for Non-Allergic […]